ES2268362T3 - Metodo para purificacion de albumina. - Google Patents

Metodo para purificacion de albumina. Download PDF

Info

Publication number
ES2268362T3
ES2268362T3 ES03725953T ES03725953T ES2268362T3 ES 2268362 T3 ES2268362 T3 ES 2268362T3 ES 03725953 T ES03725953 T ES 03725953T ES 03725953 T ES03725953 T ES 03725953T ES 2268362 T3 ES2268362 T3 ES 2268362T3
Authority
ES
Spain
Prior art keywords
matrix
hsar
ccs
stage
cation exchange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03725953T
Other languages
English (en)
Spanish (es)
Inventor
Makonnen Amersham Biosciences AB BELEW
Mei Yan North China Pharmaceutical Group Corp LI
Wei North China Pharmaceutical Group Corp. ZHANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North China Pharmaceutical Group
NORTH CHINA PHARMACEUTICAL GROUP Corp
Global Life Sciences Solutions USA LLC
Original Assignee
North China Pharmaceutical Group
NORTH CHINA PHARMACEUTICAL GROUP Corp
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North China Pharmaceutical Group, NORTH CHINA PHARMACEUTICAL GROUP Corp, GE Healthcare Bio Sciences Corp filed Critical North China Pharmaceutical Group
Application granted granted Critical
Publication of ES2268362T3 publication Critical patent/ES2268362T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES03725953T 2002-05-15 2003-05-09 Metodo para purificacion de albumina. Expired - Lifetime ES2268362T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0201518A SE526227C2 (sv) 2002-05-15 2002-05-15 Metod för rening av rekombinant humant serumalbumin
SE0201518 2002-05-15

Publications (1)

Publication Number Publication Date
ES2268362T3 true ES2268362T3 (es) 2007-03-16

Family

ID=20287916

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03725953T Expired - Lifetime ES2268362T3 (es) 2002-05-15 2003-05-09 Metodo para purificacion de albumina.

Country Status (13)

Country Link
US (2) US7423124B2 (https=)
EP (2) EP1504031B1 (https=)
JP (2) JP2006502098A (https=)
CN (1) CN100463921C (https=)
AT (1) ATE335006T1 (https=)
AU (2) AU2003228193B2 (https=)
BR (2) BRPI0309992B8 (https=)
CA (2) CA2483612A1 (https=)
DE (1) DE60307262T2 (https=)
ES (1) ES2268362T3 (https=)
IL (1) IL164844A (https=)
SE (1) SE526227C2 (https=)
WO (2) WO2003097692A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802146B2 (en) * 1998-11-06 2014-08-12 Neomend, Inc. Systems, methods, and compositions for prevention of tissue adhesion
ES2424840T3 (es) * 2003-01-28 2013-10-09 E.I. Du Pont De Nemours And Company Insecticidas tipo ciano antranilamida
CN1756587A (zh) * 2003-03-12 2006-04-05 弗雷泽纽斯卡比德国有限公司 重组白蛋白在肝衰竭后透析中的用途
HRP20060362A2 (en) * 2004-04-23 2007-03-31 Conjuchem Biotechnologies Inc. Method for the purification of albumin conjugates
CN1854155B (zh) * 2005-04-29 2010-11-17 华北制药集团新药研究开发有限责任公司 一种纯化rHSA的方法
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
AR067536A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
EP2261661A4 (en) * 2008-03-31 2011-04-20 Sekisui Medical Co Ltd CLEANED SERUM ALBUMIN AND IMMUNOLOGY MEASUREMENT PROCESS
US8753868B2 (en) * 2008-08-04 2014-06-17 General Electric Company Method and system for selective isolation of target biological molecules in a general purpose system
CN101768206B (zh) * 2008-12-31 2013-05-15 华北制药集团新药研究开发有限责任公司 一种重组人血清白蛋白的纯化方法及其应用
JP2012518409A (ja) 2009-02-20 2012-08-16 ベントリア・バイオサイエンス タンパク質の組み合わせを含有する細胞培養培地
KR101976853B1 (ko) 2010-05-25 2019-05-09 제넨테크, 인크. 폴리펩티드의 정제 방법
CN102127164B (zh) 2010-12-20 2013-01-30 武汉禾元生物科技有限公司 一种从水稻种子中提取重组人血清白蛋白的方法
CN102532254B (zh) * 2010-12-24 2015-06-24 武汉禾元生物科技股份有限公司 一种从水稻种子中分离纯化重组人血清白蛋白的方法
US9669402B2 (en) 2012-03-08 2017-06-06 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode
CN103880947B (zh) 2012-12-21 2016-01-13 武汉禾元生物科技股份有限公司 一种分离纯化高纯度重组人血清白蛋白的层析方法
CN103923211A (zh) * 2014-05-08 2014-07-16 齐智 一种医药级重组人血清白蛋白的纯化方法
EP3307876B1 (en) 2015-06-10 2023-09-13 ImmunityBio, Inc. Modified nk-92 cells for treating cancer
CN106146631A (zh) * 2015-12-09 2016-11-23 烟台大学 一种离心技术结合疏水层析介质制备藻红蛋白的方法
CN106117347A (zh) * 2015-12-09 2016-11-16 烟台大学 一种疏水层析制备高纯度藻红蛋白的方法
CN106117326A (zh) * 2015-12-09 2016-11-16 烟台大学 一种离心法结合阴离子交换层析介质制备藻红蛋白的方法
WO2021061790A1 (en) * 2019-09-24 2021-04-01 Regeneron Pharmaceuticals, Inc. Systems and methods for chromatography use and regeneration
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
KR20230060524A (ko) 2020-12-08 2023-05-04 통화 안레이트 바이오파마슈티컬 컴퍼니 리미티드 재조합 단백질의 정제 방법
JP2024500994A (ja) 2020-12-28 2024-01-10 デボル，インコーポレイテッド タンパク質及び多官能化変性ポリエチレングリコール系架橋剤を含む反応性乾燥粉末状止血用材料
CN113461804A (zh) * 2021-08-09 2021-10-01 山东健通生物科技有限公司 减少重组人血白蛋白发酵过程中色素的方法
CN113880908B (zh) * 2021-08-25 2024-05-14 北京伟德杰生物科技有限公司 纯化重组人血清白蛋白的融合蛋白的方法
CN113735962B (zh) * 2021-08-27 2023-11-10 常熟纳微生物科技有限公司 一种从猪血中纯化重组人血清白蛋白的方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093612A (en) 1975-08-04 1978-06-06 Research Corporation Selective removal of albumin from blood fluids and compositions therefore
FR2403098A1 (fr) 1977-09-19 1979-04-13 Merieux Inst Nouveau materiau capable de fixer de facon reversible des macromolecules biologiques, sa preparation et son application
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
EP0933083A1 (en) * 1991-07-12 1999-08-04 Dsm N.V. Process for the purification of serum albumin
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
CA2116385A1 (en) * 1993-02-25 1994-08-26 Akinori Sumi Human serum albumin and process for producing the same
DK0658569T3 (da) 1993-12-17 2005-02-07 Mitsubishi Pharma Corp Fremgangsmåde til affarvning af humant serumalbumin
JP3840674B2 (ja) * 1994-08-31 2006-11-01 三菱ウェルファーマ株式会社 遺伝子操作に由来するヒト血清アルブミンの精製方法
DK0699687T3 (da) * 1994-08-31 2004-04-26 Mitsubishi Pharma Corp Fremgangsmåde til oprensning af rekombinant humant serumalbumin
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
SE0002688D0 (sv) * 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法

Also Published As

Publication number Publication date
CN100463921C (zh) 2009-02-25
US20050215765A1 (en) 2005-09-29
DE60307262T2 (de) 2007-06-28
JP2006512283A (ja) 2006-04-13
SE526227C2 (sv) 2005-08-02
SE0201518D0 (sv) 2002-05-15
WO2003097693A1 (en) 2003-11-27
IL164844A (en) 2009-09-01
IL164844A0 (en) 2005-12-18
JP2006502098A (ja) 2006-01-19
US7351801B2 (en) 2008-04-01
CA2483616A1 (en) 2003-11-27
CA2483612A1 (en) 2003-11-27
BR0309992A (pt) 2005-03-01
BRPI0309992B1 (pt) 2020-12-22
US20050214902A1 (en) 2005-09-29
BRPI0309992B8 (pt) 2023-03-21
AU2003232704A1 (en) 2003-12-02
AU2003228193A1 (en) 2003-12-02
DE60307262D1 (de) 2006-09-14
JP4559216B2 (ja) 2010-10-06
EP1504032A1 (en) 2005-02-09
CN1496993A (zh) 2004-05-19
WO2003097692A1 (en) 2003-11-27
AU2003228193B2 (en) 2009-05-07
US7423124B2 (en) 2008-09-09
EP1504031A1 (en) 2005-02-09
EP1504031B1 (en) 2006-08-02
ATE335006T1 (de) 2006-08-15

Similar Documents

Publication Publication Date Title
ES2268362T3 (es) Metodo para purificacion de albumina.
Gaberc-Porekar et al. Perspectives of immobilized-metal affinity chromatography
ES2710204T3 (es) Matrices de cromatografía que incluyen nuevos ligandos basados en la proteína A de Staphylococcus aureus
ES2225847T3 (es) Resinas cromatograficas y metodos para usar las mismas.
ES2612572T3 (es) Matriz de cromatografía
JP5298242B2 (ja) アフィニティークロマトグラフィー用担体およびイムノグロブリンを単離する方法
ES2211961T3 (es) Procedimiento para la obtencion de eritropoyetina libre de proteinas animales.
US20100168395A1 (en) Novel polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin
AU735480B2 (en) A process for preparing human proinsulin
ES2552337T3 (es) Procedimientos para la preparación de plasminógeno
JP2004532182A (ja) 低濃度の塩を含有する組成物の製造方法
ES2952767T3 (es) Método de producción para resina de cromatografía de afinidad
WO2023109963A1 (zh) 突变的蛋白a结构域c及其应用
ES2304638T3 (es) Purificacion de inmunoglobulinas.
JP5306568B2 (ja) 吸着方法およびリガンド
CN100387614C (zh) 包涵体蛋白复性并同时纯化的方法
JP6722187B2 (ja) アフィニティー担体およびイムノグロブリンを単離する方法
Mizutani Adsorption chromatography of biopolymers on porous glass
CN109678932B (zh) 一种IgG抗体亲和的小分子肽及其应用
US3926730A (en) Separation and purification of alpha-amylase
KR100409092B1 (ko) 단백질의 제조 방법
KR20050016877A (ko) 알부민 정제 방법
CN119080892A (zh) 突变的蛋白a结构域及其应用
WO1991018009A1 (en) A process for the purification of proteins